Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
about
Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionPathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.The preclinical natural history of serous ovarian cancer: defining the target for early detectionEarly detection of ovarian cancerDoes bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer.Novel surgical approaches for sampling the ovarian surface epithelium and proximal fluid proteomeModeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early DetectionRisk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine FibroidsMathematical models of breast and ovarian cancers.Ovarian cancer stroma: pathophysiology and the roles in cancer development.Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.BRCA and Early Events in the Development of Serous Ovarian Cancer.Pathogenesis and heterogeneity of ovarian cancer.HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.Hereditary gynaecological malignancies: advances in screening and treatment.Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry."Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty".Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions.[Serous genital carcinoma: molecular pathogenesis and the role of tubal fimbria].[Hereditary breast and ovarian cancer].
P2860
Q26747279-C65213CA-0CDC-4478-9F7F-26C19349E8C2Q30370475-A516649A-9147-4A33-BB46-9861561B7CC8Q33487678-F8F7B3B8-34D5-40D7-AAB6-2A7EADA6D649Q34094731-D9E1AAA5-FAA3-46CA-BEC9-A4EFFD3550A0Q34125241-A4BD7C52-5892-49EE-981D-D7845D1C9AECQ34172655-FF28E488-2EE8-46A2-B3E2-A448F236DB62Q34288214-67FC7FB6-13D0-4EF2-9FEB-D2C8053729C7Q34625221-9747DA61-AABD-4E45-ACB9-4491947F2ECBQ35219159-00F4FBDF-9EE1-4E32-8E3A-180CE35B7ED0Q35308231-905D212F-89C5-448A-844A-8CB1816AC9B4Q36039369-89BB3B05-3931-4755-B2AE-F450083A82E8Q36313479-95DF85C9-8DC5-48BF-B691-A4D1DD06800FQ36369334-4E9449A4-383B-46BD-BCA4-5EBBD32E5A3BQ36791100-3E4F6AF2-70E8-496B-BCAB-0335B0284F2BQ37014152-AA091E2F-0999-4E9A-93EB-E1415B38B2E8Q37017056-C6E0B2B2-C981-4852-94FC-921843956D1EQ37125079-AC70B7F8-62B1-42B7-9843-154D7BD74D33Q37163464-93881311-E1F1-4E1C-BDB3-8DDC2730B5AFQ37406838-E9F4D4AC-AC9F-4314-8DA0-3E40218D0BA0Q37513137-DFF7BC33-A4E7-48E0-9DCD-759284C400FBQ37546692-AA75A9D4-4837-4A0A-B488-18D78E72E0F4Q37611329-EB72AFB2-E5B4-4D3A-B922-8DCE9CFE5DD0Q38039167-1B6D38C8-DEDF-4F70-922B-117CFA16B02BQ38067433-B469008A-F3EC-47B3-ACA9-089F3B32A542Q38067435-8FB76680-7210-4016-803C-273E86674980Q38978839-FFE506AD-B968-4DB9-982D-BF8758B5965BQ43625600-D680D7B7-6D6D-46AF-B41F-919A75F63383Q47162185-8EA236E9-CCBD-4C3B-AF55-77B528F4BB6CQ49184692-2A94CBE6-E49D-4D39-85C8-D9DD7D0EB360Q53305324-31BF82EF-7DCF-4638-ABFA-AACD184E5504Q53738265-73AA9E77-0E13-4DD1-805A-CE04BC00EEA9
P2860
Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Incidental carcinomas in proph ...... and review of the literature.
@ast
Incidental carcinomas in proph ...... and review of the literature.
@en
type
label
Incidental carcinomas in proph ...... and review of the literature.
@ast
Incidental carcinomas in proph ...... and review of the literature.
@en
prefLabel
Incidental carcinomas in proph ...... and review of the literature.
@ast
Incidental carcinomas in proph ...... and review of the literature.
@en
P2093
P50
P1476
Incidental carcinomas in proph ...... and review of the literature.
@en
P2093
Barbara Pasini
Gianbattista Spatti
Maria L Carcangiu
P304
P356
10.1097/01.PAS.0000202161.80739.AC
P407
P577
2006-10-01T00:00:00Z